Treatments Appear No Better Than Placebo for Tennis Elbow
FRIDAY, Nov. 16, 2018 -- At best, all treatments provide only small pain relief for tennis elbow, according to a review published online Oct. 31 in the American Journal of Sports Medicine.
Jays
Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
Audience: Patient, Caregiver, Health Professional, Pain Management, Pharmacy, Neurology, Surgery
ISSUE: The FDA is aware that patients unde
FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
BOTHELL, Wash.--(BUSINESS WIRE)--Nov. 16, 2018-
Income, Lifestyle May Contribute to Disparity in Cancer Deaths
FRIDAY, Nov. 9, 2018 -- Socioeconomic and health-related behaviors contribute to county-level disparities in cancer deaths, according to a study published online Oct. 5 in JAMA Network Open.
FDA Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today an
RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA) granted approval of its New Drug Application (NDA) for Primatene Mist (epinephrine